+44 79 19 49 39 39 wilsonblaney@gmail.com

Complaints about UK medical advertising drop
Johnson & Johnson filed a complaint to the MHRA concerning a TV advertisement produced by Omega Pharma for Bronchostop, a traditional herbal medicine licensed on the basis of evidence of traditional usage that wrongly suggesting the efficacy of the …
Read more on PMLiVE


UK’s MHRA commits to create user friendly packaging for dementia medicines
Life Sciences Minister George Freeman said: “Dementia is a devastating condition, which is why we are committed to ensuring that the UK becomes a world-leader in care, support and research by 2020 – thanks to the Prime Minister’s challenge on dementia.
Read more on Packaging Business Review


UK’s MHRA clears ProMetic’s CTA for PBI-4050 anti-fibrotic lead drug candidate
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has cleared ProMetic Life Sciences’ clinical trial application (CTA) for its anti-fibrotic lead drug candidate PBI-4050 in patients with type 2 diabetes and severe multi-organ fibrosis.
Read more on Pharmaceutical Business Review


Share Button